Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
Clinical trial NCT07472972 · RECRUITING
Trial details
- NCT number
- NCT07472972
- Sponsor
- University of Zurich
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-20
- Primary completion
- 2028-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.